Bailey D M, Hansen P E, Hlavac A G, Baizman E R, Pearl J, DeFelice A F, Feigenson M E
J Med Chem. 1985 Feb;28(2):256-60. doi: 10.1021/jm00380a020.
A small series of compounds is described in which a narrow SAR has identified N,N-dimethyl-3,4-diphenyl-1H-pyrazole-1-propanamine, 3, as a potential antidepressant with reduced side effects. The isomeric N,N-dimethyl-4,5-diphenyl-1H-pyrazole-1-propanamine was completely inactive in the primary antidepressant screens. Compounds were synthesized by Michael addition of acrylonitrile to diphenylpyrazole followed by reductive alkylation of the resultant diphenylpyrazolepropionitriles. Compound 3 was equipotent with imipramine in standard antidepressant assays in animals but showed no significant anticholinergic action and did not antagonize the antihypertensive effects of clonidine and guanethidine.
描述了一小系列化合物,其中通过狭窄的构效关系确定N,N-二甲基-3,4-二苯基-1H-吡唑-1-丙胺(3)是一种具有减少副作用的潜在抗抑郁药。异构体N,N-二甲基-4,5-二苯基-1H-吡唑-1-丙胺在主要抗抑郁筛选中完全无活性。化合物通过丙烯腈对二苯基吡唑的迈克尔加成反应,然后对所得二苯基吡唑丙腈进行还原烷基化反应合成。在动物的标准抗抑郁试验中,化合物3与丙咪嗪等效,但未显示出明显的抗胆碱能作用,也未拮抗可乐定和胍乙啶的降压作用。